Scientists in Canada have discovered a metabolic pathway that will allow the development of drugs that target parasites, such as roundworms, hookworms and tapeworms, which affect over one billion people across the world.
According to the World Health Organisation (WHO), over one billion people, including 880 million children, are infected with intestinal nematode worms.


